Changzhou Qianhong Biopharma Co., Ltd Announces Executive Elections At the Extraordinary General Meeting Held on January 28, 2021
January 29, 2021 at 02:32 pm EST
Share
Changzhou Qianhong Biopharma CO.,LTD announced election of Zhou Xiang as a non-independent director, Ning Ao as an independent director, Xu Guanghua as an independent director, Ren Shengxiang as an independent director and Hua Juanwei as a non-employee supervisor at the Extraordinary General Meeting held on January 28, 2021.
Changzhou Qianhong Biopharma CO., LTD is a China-based company, principally engaged in the research and development, production and distribution of freeze-drying powder, freeze-drying powder injections, small volume injections, tablets, hard capsules, granules and bulk drugs, among others. The Company mainly provides liquaemin sodium raw materials and preparations, applied to prevent and treat thromboembolism desease; kallidinogen preparations, applied in the treatment of micro-circulation disorder disease, asparaginase bulk drugs and preparations, applied in the treatment of acute lymphoblastic leukemia, as well as compound digestive enzyme capsules II. The Company distributes its products within domestic market and to overseas markets.
CHANGZHOU QIANHONG BIOPHARMA CO.,LTD 
